Insider track record Other Across 27 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by James Ford. Insider active across 1 company, notably GSK plc. Aggregated, 93 disclosures have been logged. History available since 9 August 2023. The latest transaction was filed on 9 June 2026 (Purchase). Regulator: RNS (LSE). All data is free.
Declarations 93 total
● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:9614374-2 Ideal exit: 6 Mar 2027 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:03338973-0058-4811-9fe5-7b22157346a2-2 Ideal exit: 6 Mar 2027 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 12 May 2026 · GSK plc 14 shares @ £18.6557 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:eaad27f1-a91f-4bc4-815a-149202956de0-2 Ideal exit: 6 Feb 2027 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 14 Apr 2026 · GSK plc 653 shares @ £21.67 0.0000% mcap 0.1% of flow GB00BN7SWP63⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-3 ● SVP and Group General Counsel, Legal and Compliance · Executives · 13 Apr 2026 · GSK plc 10 shares @ £21.709 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:bae2311e-28b0-4835-a894-0209eedccba9-2 Ideal exit: 8 Jan 2027 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Apr 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:66208821-3d67-43ba-837e-411f45d449f1-8 Ideal exit: 4 Jan 2027 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Apr 2026 · GSK plc 10 shares @ £21.339 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-3 Ideal exit: 4 Jan 2027 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow GB00BN7SWP63⌘ RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-2 Ideal exit: 5 Dec 2026 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 13 Feb 2026 · GSK plc 159,845 shares 0
GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-8 ● SVP and Group General Counsel, Legal and Compliance · Executives · 13 Feb 2026 · GSK plc 75,128 shares @ £21.6002 9.5% of flow GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-9 ● SVP and Group General Counsel, Legal and Compliance · Executives · 12 Feb 2026 · GSK plc 13,229 shares @ £21.50 1.7% of flow GB00BN7SWP63⌘ RNS:6207777f-2477-470b-868f-21f92714189a-3 ● SVP and Group General Counsel, Legal and Compliance · Executives · 12 Feb 2026 · GSK plc 133,977 shares @ £21.50 16.9% of flow GB00BN7SWP63⌘ RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-4 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Feb 2026 · GSK plc 25,045 shares 0
GB00BN7SWP63⌘ RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-4 ● SVP and Group General Counsel, Legal and Compliance · Executives · 10 Feb 2026 · GSK plc 12 shares @ £21.7917 0.0% of flow GB00BN7SWP63⌘ RNS:f7024c14-f781-4e48-a904-495085bc7ca2-2 Ideal exit: 7 Nov 2026 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Feb 2026 · GSK plc 11,789 shares @ £22.0057 1.5% of flow GB00BN7SWP63⌘ RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-5 ● SVP and Group General Counsel, Legal and Compliance · Executives · 8 Jan 2026 · GSK plc 9 shares @ £18.9433 0.0% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-4 Ideal exit: 5 Oct 2026 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 12 Jan 2026 · GSK plc 14 shares @ £18.9321 0.0% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-44 Ideal exit: 9 Oct 2026 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 8 Jan 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-14 Ideal exit: 5 Oct 2026 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Jan 2026 · GSK plc 760 shares @ £18.91 0.1% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-27 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Dec 2025 · GSK plc 12 shares @ £18.0783 0.0% of flow GB00BN7SWP63⌘ RNS:58b71e9c-e0b4-4fdd-8b21-5f1119d38ddd-2 Ideal exit: 5 Sept 2026 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 28 Nov 2025 · GSK plc 643 shares @ £14.19 0.1% of flow GB00BN7SWP63⌘ RNS:0ba74213-2a39-4226-8c3a-7a678946c4c7-0 ● SVP and Group General Counsel, Legal and Compliance · Executives · 11 Nov 2025 · GSK plc 14 shares @ £18.1421 0.0% of flow GB00BN7SWP63⌘ RNS:802a4789-60c0-4a7f-a34b-b750f1d9f048-2 Ideal exit: 8 Aug 2026 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 10 Oct 2025 · GSK plc 867 shares @ £16.40 0.1% of flow GB00BN7SWP63⌘ RNS:5862277-3 ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Oct 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5859068-15 Ideal exit: 6 Jul 2026 (T+270) ● SVP and Group General Counsel, Legal and Compliance · Executives · 9 Oct 2025 · GSK plc 11 shares @ £16.3918 0.0% of flow GB00BN7SWP63⌘ RNS:5859068-2 Ideal exit: 6 Jul 2026 (T+270) 25 of 93 declarations
Load more (68 remaining) About James Ford James Ford is a declarant who has made 93 filings in total. In his most recent filings, he made a purchase totaling 12,378 EUR and sales totaling 8,072,972 EUR, with the first filing date on August 10, 2023, and the last on June 12, 2026. His filings include notable transactions, such as an amount of 3,345,214.57 EUR published on February 21, 2025, and an amount of 3,304,112.74 EUR published on February 16, 2026.